Search research articles
Contact Us
Filters
Showing results (231-240 of 263) with videos related to
Page
of 27
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 9, 2011
Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials
Thomas N Kakuda, Samantha Abel, John Davis, et al.
Disability and Rehabilitation
|
February 3, 2025
The long road back to physical activity: the experience of people with moderate-to-severe traumatic brain injury
Abby Haynes, Liam Johnson, Rhys Ashpole, et al.
Biophysical Journal
|
November 1, 1992
Looking at proteins: representations, folding, packing, and design. Biophysical Society National Lecture, 1992
J S Richardson, D C Richardson, N B Tweedy, et al.
Selective Cancer Therapeutics
|
January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule
P W Cobb, K A Havlin, J G Kuhn, et al.
Plos Biology
|
April 2, 2026
Macrophages self-generate and refine chemotactic gradients during migration towards complement C5a
Abhimanyu Kiran, Peter A Thomason, David M Versluis, et al.
Annals of Biomedical Engineering
|
December 7, 2016
Rotor Tracking Using Phase of Electrograms Recorded During Atrial Fibrillation
Caroline H Roney, Chris D Cantwell, Norman A Qureshi, et al.
Disability and Rehabilitation
|
August 20, 2010
Boosting in athletes with high-level spinal cord injury: knowledge, incidence and attitudes of athletes in paralympic sport
Yagesh Bhambhani, Jennifer Mactavish, Sharon Warren, et al.
Circulation. Arrhythmia and Electrophysiology
|
May 14, 2017
Spatial Resolution Requirements for Accurate Identification of Drivers of Atrial Fibrillation
Caroline H Roney, Chris D Cantwell, Jason D Bayer, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Neurobiology of Disease
|
December 21, 2020
Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein
Clare Tweedy, Nathan Kindred, Joshua Curry, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 263) with videos related to
Sort By:
Page
of 27
Antimicrobial Agents and Chemotherapy
|
March 9, 2011
Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials
Thomas N Kakuda, Samantha Abel, John Davis, et al.
Disability and Rehabilitation
|
February 3, 2025
The long road back to physical activity: the experience of people with moderate-to-severe traumatic brain injury
Abby Haynes, Liam Johnson, Rhys Ashpole, et al.
Biophysical Journal
|
November 1, 1992
Looking at proteins: representations, folding, packing, and design. Biophysical Society National Lecture, 1992
J S Richardson, D C Richardson, N B Tweedy, et al.
Selective Cancer Therapeutics
|
January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule
P W Cobb, K A Havlin, J G Kuhn, et al.
Plos Biology
|
April 2, 2026
Macrophages self-generate and refine chemotactic gradients during migration towards complement C5a
Abhimanyu Kiran, Peter A Thomason, David M Versluis, et al.
Annals of Biomedical Engineering
|
December 7, 2016
Rotor Tracking Using Phase of Electrograms Recorded During Atrial Fibrillation
Caroline H Roney, Chris D Cantwell, Norman A Qureshi, et al.
Disability and Rehabilitation
|
August 20, 2010
Boosting in athletes with high-level spinal cord injury: knowledge, incidence and attitudes of athletes in paralympic sport
Yagesh Bhambhani, Jennifer Mactavish, Sharon Warren, et al.
Circulation. Arrhythmia and Electrophysiology
|
May 14, 2017
Spatial Resolution Requirements for Accurate Identification of Drivers of Atrial Fibrillation
Caroline H Roney, Chris D Cantwell, Jason D Bayer, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Neurobiology of Disease
|
December 21, 2020
Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein
Clare Tweedy, Nathan Kindred, Joshua Curry, et al.
Page
of 27